Skip to content

Clinical trials

Recruiting alpha 1-Antitrypsin Deficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Status: Recruiting Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20191
20231
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda3
University of Florida2
Alpha-1 Foundation1
Beam Therapeutics Inc.1
Columbia University1
Grifols Therapeutics LLC1
Krystal Biotech, Inc.1
National Heart, Lung, and Blood Institute (NHLBI)1
Tessera Therapeutics, Inc.1
University of Alabama at Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency14
Pulmonary Disease, Chronic Obstructive4
Emphysema3
Cystic Fibrosis2
Lung Diseases2
Asthma1
Genetic Diseases, Inborn1
Lung Diseases, Obstructive1
Pathologic Processes1
Pulmonary Emphysema1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.